The Oncology Institute(TOI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TOI The Oncology Institute

Closed Good Friday 04-02 16:00:00 EDT

3.12

-0.02

-0.64%

盘后3.13

+0.01+0.32%

18:39 EDT

High3.15	Low2.99	Vol640.19K
Open3.01	D1 Closing3.14	Amplitude5.10%
Mkt Cap306.95M	Tradable Cap257.21M	Total Shares98.38M
T/O1.99M	T/O Rate0.78%	Tradable Shares82.44M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"TOI","market":"US","secType":"STK","nameCN":"The Oncology Institute","latestPrice":3.12,"timestamp":1775160000000,"preClose":3.14,"halted":0,"volume":640189,"hourTrading":{"tag":"盘后","latestPrice":3.13,"preClose":3.12,"latestTime":"18:39 EDT","volume":1936,"amount":6043.26,"timestamp":1775169544024,"change":0.01,"changeRate":0.003205,"amplitude":0.003205},"delay":0,"changeRate":-0.006369426751592362,"floatShares":82439500,"shares":98381340,"eps":-0.544488,"marketStatus":"Closed Good Friday","change":-0.02,"latestTime":"04-02 16:00:00 EDT","open":3.01,"high":3.15,"low":2.99,"amount":1985420.0022481,"amplitude":0.050955,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.544488,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1775462400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":3.14,"preHourTrading":{"tag":"盘前","latestPrice":3.04,"preClose":3.14,"latestTime":"09:14 EDT","volume":2130,"amount":6328.948449,"timestamp":1775135657994,"change":-0.1,"changeRate":-0.031847,"amplitude":0.142707},"postHourTrading":{"tag":"盘后","latestPrice":3.13,"preClose":3.12,"latestTime":"18:39 EDT","volume":1936,"amount":6043.26,"timestamp":1775169544024,"change":0.01,"changeRate":0.003205,"amplitude":0.003205},"volumeRatio":0.3878917767890877,"impliedVol":0.7211,"impliedVolPercentile":0.2229},"requestUrl":"/m/hq/s/TOI","defaultTab":"news","newsList":[{"id":"2623501345","title":"Oncology Institute 10% owner Jorey Chernett acquires $0.08 million common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2623501345","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623501345?lang=en_us&edition=fundamental","pubTime":"2026-03-30 21:39","pubTimestamp":1774877951,"startTime":"0","endTime":"0","summary":"Oncology Institute 10% owner Jorey Chernett reported a purchase of 27,429 common shares at USD 2.96.Chernett’s direct holding rose to 10,479,358 shares following transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Oncology Institute Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 30, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL7KcLfL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Oncology Institute 10% owner Jorey Chernett acquires $0.08 million common shares","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TOI","BK4185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622802653","title":"Major Investor Quietly Boosts Position in The Oncology Institute","url":"https://stock-news.laohu8.com/highlight/detail?id=2622802653","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622802653?lang=en_us&edition=fundamental","pubTime":"2026-03-28 10:02","pubTimestamp":1774663374,"startTime":"0","endTime":"0","summary":"New insider activity at Oncology Institute ( ($TOI) ) has taken place on March 27, 2026. Significant shareholder Chernett Jorey has increased their...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-investor-quietly-boosts-position-in-the-oncology-institute-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-investor-quietly-boosts-position-in-the-oncology-institute-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4185","TOI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622822212","title":"Jorey Chernett, 10% owner; acquires The Oncology Institute common shares valued at $158,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2622822212","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622822212?lang=en_us&edition=fundamental","pubTime":"2026-03-27 21:37","pubTimestamp":1774618651,"startTime":"0","endTime":"0","summary":"Jorey Chernett, a 10% owner of Oncology Institute, reported a purchase of 50,000 common shares.The shares were acquired at a weighted average price of USD 3.15 per share.Following the reported transaction, Chernett beneficially owned 10,451,929 common shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Oncology Institute Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 27, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nNDL8PSZKS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Jorey Chernett, 10% owner; acquires The Oncology Institute common shares valued at $158,000","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4185","TOI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622071392","title":"Jorey Chernett; acquires 125,000 The Oncology Institute common shares valued at $388,750","url":"https://stock-news.laohu8.com/highlight/detail?id=2622071392","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622071392?lang=en_us&edition=fundamental","pubTime":"2026-03-25 21:33","pubTimestamp":1774445626,"startTime":"0","endTime":"0","summary":"Jorey Chernett, a 10% owner of The Oncology Institute, acquired 125,000 shares of Common Stock in an open-market purchase.Ownership of Common Stock increases to 10.4 million shares following the transaction.The purchase price is listed at $3.11 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Oncology Institute Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 25, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDL61Kj8W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Jorey Chernett; acquires 125,000 The Oncology Institute common shares valued at $388,750","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TOI","BK4185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621435034","title":"Major Investor Quietly Boosts Stake in The Oncology Institute","url":"https://stock-news.laohu8.com/highlight/detail?id=2621435034","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621435034?lang=en_us&edition=fundamental","pubTime":"2026-03-24 10:06","pubTimestamp":1774317974,"startTime":"0","endTime":"0","summary":"New insider activity at Oncology Institute ( ($TOI) ) has taken place on March 23, 2026. Significant shareholder Chernett Jorey has expanded their ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-investor-quietly-boosts-stake-in-the-oncology-institute-insider-trading-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-investor-quietly-boosts-stake-in-the-oncology-institute-insider-trading-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4185","TOI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621709198","title":"10% owner Jorey Chernett acquires USD 83,750 of The Oncology Institute common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2621709198","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621709198?lang=en_us&edition=fundamental","pubTime":"2026-03-23 21:33","pubTimestamp":1774272825,"startTime":"0","endTime":"0","summary":"Jorey Chernett, a 10% owner of Oncology Institute, reported buying 25,000 common shares.The reported weighted average purchase price was USD 3.35 per share.Following the transaction, Chernett reported beneficial ownership of 10,276,929 common shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Oncology Institute Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 23, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nNDL9nRYZd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"10% owner Jorey Chernett acquires USD 83,750 of The Oncology Institute common shares","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TOI","BK4185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621075178","title":"The Oncology Institute files initial beneficial ownership statement for director Kimberly Jo Tzoumakas","url":"https://stock-news.laohu8.com/highlight/detail?id=2621075178","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621075178?lang=en_us&edition=fundamental","pubTime":"2026-03-21 04:34","pubTimestamp":1774038882,"startTime":"0","endTime":"0","summary":"Oncology Institute director Kimberly Tzoumakas filed a Form 3 initial statement of beneficial ownership covering an event dated Feb. 23, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Oncology Institute Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 20, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nNDL2YvrhZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TOI","BK4185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620288410","title":"Major Investor Quietly Boosts Stake in The Oncology Institute","url":"https://stock-news.laohu8.com/highlight/detail?id=2620288410","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620288410?lang=en_us&edition=fundamental","pubTime":"2026-03-18 10:06","pubTimestamp":1773799578,"startTime":"0","endTime":"0","summary":"New insider activity at Oncology Institute ( ($TOI) ) has taken place on March 17, 2026. Significant shareholder Chernett Jorey has expanded their ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-investor-quietly-boosts-stake-in-the-oncology-institute-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-investor-quietly-boosts-stake-in-the-oncology-institute-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4185","TOI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620014734","title":"The Oncology Institute 10% owner Jorey Chernett acquires USD 1.13 million in common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2620014734","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620014734?lang=en_us&edition=fundamental","pubTime":"2026-03-18 07:40","pubTimestamp":1773790841,"startTime":"0","endTime":"0","summary":"Jorey Chernett, a 10% owner of Oncology Institute, reported purchases of 398,985 common shares. The reported purchase prices were USD 2.92 per share and USD 3.42 per share. Following the transactions, Chernett beneficially owned 10,251,929 common shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Oncology Institute Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 17, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDL95Cv2b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"The Oncology Institute 10% owner Jorey Chernett acquires USD 1.13 million in common shares","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TOI","BK4185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619468259","title":"The Oncology Institute Inc. files Form 3 initial beneficial ownership statement for Jorey Chernett","url":"https://stock-news.laohu8.com/highlight/detail?id=2619468259","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619468259?lang=en_us&edition=fundamental","pubTime":"2026-03-16 20:32","pubTimestamp":1773664366,"startTime":"0","endTime":"0","summary":"Jorey Chernett filed a Form 3 initial beneficial ownership statement for Oncology Institute, trading symbol TOI. The filing reported direct ownership of 9,852,944 shares of common stock with $0.0001 par value. Chernett was listed as a 10% owner, and the event date requiring the statement was 03/13/2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Oncology Institute Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 16, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nNDLbdsc4C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TOI","BK4185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619818146","title":"Oncology Institute (TOI) Q4 Loss Per Share Improvement Tests Longstanding Profitability Doubts","url":"https://stock-news.laohu8.com/highlight/detail?id=2619818146","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619818146?lang=en_us&edition=fundamental","pubTime":"2026-03-14 06:24","pubTimestamp":1773440657,"startTime":"0","endTime":"0","summary":"Oncology Institute (TOI) closed out FY 2025 with Q4 revenue of US$142.0 million and a basic EPS loss of US$0.07, while trailing twelve month figures show revenue of US$502.7 million and a net loss of US$60.6 million. The company has seen quarterly revenue move from US$100.3 million in Q4 2024 to US$142.0 million in Q4 2025, with basic EPS losses ranging from US$0.21 in Q1 2025 to US$0.07 in Q4, presenting a picture in which top line scale is increasing while margins remain clearly...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-toi/oncology-institute/news/oncology-institute-toi-q4-loss-per-share-improvement-tests-l","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-toi/oncology-institute/news/oncology-institute-toi-q4-loss-per-share-improvement-tests-l","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4185","TOI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619194187","title":"B. Riley Adjusts Price Target on Oncology Institute to $8 From $6, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2619194187","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619194187?lang=en_us&edition=fundamental","pubTime":"2026-03-13 19:59","pubTimestamp":1773403191,"startTime":"0","endTime":"0","summary":"B. Riley Adjusts Price Target on Oncology Institute to $8 From $6, Maintains Buy Rating","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4185","TOI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619219165","title":"Oncology Institute Price Target Maintained With a $5.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2619219165","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619219165?lang=en_us&edition=fundamental","pubTime":"2026-03-13 19:31","pubTimestamp":1773401460,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TOI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 13, 2026 07:31 ET (11:31 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TOI","BK4185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619193990","title":"Why Oncology Institute Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=2619193990","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619193990?lang=en_us&edition=fundamental","pubTime":"2026-03-13 17:41","pubTimestamp":1773394860,"startTime":"0","endTime":"0","summary":"The Oncology Institute (TOI) stock rose in pre-market trading after reporting better-than-expected financial results. Other gainers include ISPC, PAYP, and EONR.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/13/Display-Of-Stock-Market-Quotes.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/13/Display-Of-Stock-Market-Quotes.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/26/03/51234968/why-oncology-institute-shares-are-trading-higher-by-around-15-here-are-20-stocks-moving-premarket","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/26/03/51234968/why-oncology-institute-shares-are-trading-higher-by-around-15-here-are-20-stocks-moving-premarket","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4185","TOI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619155775","title":"Oncology Institute Q4 Loss Narrows, Revenue Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2619155775","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619155775?lang=en_us&edition=fundamental","pubTime":"2026-03-13 05:58","pubTimestamp":1773352728,"startTime":"0","endTime":"0","summary":"Oncology Institute  reported a Q4 loss late Thursday of $0.06 per diluted share, narrowing from the loss of $0.14 a year earlier.Four analysts polled by FactSet expected a loss of $0.09.Revenue for the three months ended Dec. 31 rose to $142 million from $100.3 million a year earlier.Four analysts expected $139.8 million.The company expects full-year 2026 revenue of $630 million to $650 million.Four analysts project $636.2 million.Oncology Institute shares rose 13% in after-hours trading.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4185","TOI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618942069","title":"Tempus AI study finds 12% of community oncology patients gain actionable results from advanced genomic profiling features","url":"https://stock-news.laohu8.com/highlight/detail?id=2618942069","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618942069?lang=en_us&edition=fundamental","pubTime":"2026-03-11 20:31","pubTimestamp":1773232260,"startTime":"0","endTime":"0","summary":"Tempus reported a clinical study published in JCO Precision Oncology evaluating advanced features of comprehensive genomic profiling in community oncology settings. The study was conducted with The Oncology Institute and assessed tumor-normal matched sequencing, RNA sequencing, and liquid biopsy reflex testing. Across pilot and expanded cohorts, 12% of patients had potentially actionable findings tied to an approved therapy that were identified only through these advanced profiling features. The announcement did not state that results were previously presented or scheduled for future presentation.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nNDL2bgzhY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861558580.USD","BK4611","TOI","BK4121","BK4613","TEMT","TEM","BK4185","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2618969325","title":"Oncology Institute Inc  expected to post a loss of 9 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2618969325","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618969325?lang=en_us&edition=fundamental","pubTime":"2026-03-11 04:17","pubTimestamp":1773173825,"startTime":"0","endTime":"0","summary":"Oncology Institute Inc  expected to post a loss of9cents a share - Earnings Preview Oncology Institute Inc TOI.OQ TOI.O is expected to  show a rise in quarterly revenue when it reports  results on Mar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nL8N3ZY2IW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4185","TOI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618647470","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Roche Holding AG (OtherRHHVF), Incyte (INCY) and Oncology Institute (TOI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618647470","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618647470?lang=en_us&edition=fundamental","pubTime":"2026-03-09 18:40","pubTimestamp":1773052830,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Roche Holding AG (RHHVF – Research Report), Incyte...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-roche-holding-ag-otherrhhvf-incyte-incy-and-oncology-institute-toi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-roche-holding-ag-otherrhhvf-incyte-incy-and-oncology-institute-toi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INCY","BK4185","AG","BK4137","BK4532","LABU","LU0029874061.USD","BK4588","XLV","BK4139","XBI","LU0128526141.USD","BK4581","TOI","BK4585","HCSG","BK4550","BK4210"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618429406","title":"Oncology Institute Price Target Maintained With a $7.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2618429406","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618429406?lang=en_us&edition=fundamental","pubTime":"2026-03-09 18:05","pubTimestamp":1773050700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TOI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 09, 2026 06:05 ET (10:05 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4185","TOI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614044659","title":"The Oncology Institute Inc. published an update to their financial calendar","url":"https://stock-news.laohu8.com/highlight/detail?id=2614044659","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614044659?lang=en_us&edition=fundamental","pubTime":"2026-02-26 21:03","pubTimestamp":1772111005,"startTime":"0","endTime":"0","summary":"The Oncology Institute Inc. published an update to their financial calendar               The Oncology Institute Inc. will release its fourth quarter and full year 2025 financial results on Thursday, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nNDL9mBvg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","TOI","IE00B64PRP62.GBP","BK4185","LU0314104364.USD","LU2095319765.USD","LU2210150020.SGD","SG9999014005.SGD","SG9999014039.USD","BK4112","IE00BKPKM429.USD","LU2210149790.SGD","BK4585","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","NDAQ","BK4588","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.theoncologyinstitute.com","stockEarnings":[{"period":"1week","weight":0.0065},{"period":"1month","weight":0.1556},{"period":"3month","weight":-0.1499},{"period":"6month","weight":-0.1429},{"period":"1year","weight":1.1081},{"period":"ytd","weight":-0.1236}],"compareEarnings":[{"period":"1week","weight":0.0166},{"period":"1month","weight":-0.036},{"period":"3month","weight":-0.04},{"period":"6month","weight":-0.02},{"period":"1year","weight":0.1617},{"period":"ytd","weight":-0.0383}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates in three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient blood product transfusions, and patient support services. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.260474},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.061864},{"month":3,"riseRate":0.5,"avgChangeRate":-0.006328},{"month":4,"riseRate":0.666667,"avgChangeRate":0.122565},{"month":5,"riseRate":0.4,"avgChangeRate":-0.057716},{"month":6,"riseRate":0.5,"avgChangeRate":-0.094312},{"month":7,"riseRate":0.833333,"avgChangeRate":0.340043},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.040327},{"month":9,"riseRate":0.5,"avgChangeRate":-0.018468},{"month":10,"riseRate":0.5,"avgChangeRate":0.091691},{"month":11,"riseRate":0,"avgChangeRate":-0.319754},{"month":12,"riseRate":1,"avgChangeRate":0.32933}],"exchange":"NASDAQ","name":"The Oncology Institute","nameEN":"The Oncology Institute"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"The Oncology Institute(TOI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest The Oncology Institute(TOI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"The Oncology Institute,TOI,The Oncology Institute股票,The Oncology Institute股票老虎,The Oncology Institute股票老虎国际,The Oncology Institute行情,The Oncology Institute股票行情,The Oncology Institute股价,The Oncology Institute股市,The Oncology Institute股票价格,The Oncology Institute股票交易,The Oncology Institute股票购买,The Oncology Institute股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"The Oncology Institute(TOI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest The Oncology Institute(TOI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}